Arkolith/Insider Trading/JSPR/Form 4

Wiggans Thomas G

DirectorJasper Therapeutics, Inc. (JSPR) · full profile →Form 4 · filed Nov 20, 2023
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 20, 2023Buy(P)10K$0.63$6K30K
Nov 17, 2023Buy(P)10K$0.60$6K20K
Nov 16, 2023Buy(P)10K$0.60$6K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-088896) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML